These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12845652)

  • 1. Baicalein and baicalin are potent inhibitors of angiogenesis: Inhibition of endothelial cell proliferation, migration and differentiation.
    Liu JJ; Huang TS; Cheng WF; Lu FJ
    Int J Cancer; 2003 Sep; 106(4):559-565. PubMed ID: 12845652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
    Yeh CH; Peng HC; Yang RS; Huang TF
    Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo.
    Liu JM; Lawrence F; Kovacevic M; Bignon J; Papadimitriou E; Lallemand JY; Katsoris P; Potier P; Fromes Y; Wdzieczak-Bakala J
    Blood; 2003 Apr; 101(8):3014-20. PubMed ID: 12480715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose Dependent Dual Effect of Baicalin and Herb Huang Qin Extract on Angiogenesis.
    Zhu D; Wang S; Lawless J; He J; Zheng Z
    PLoS One; 2016; 11(11):e0167125. PubMed ID: 27902752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel function of ascorbic acid as an angiostatic factor.
    Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
    Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro effect of baicalein on human prostate cancer cells.
    Miocinovic R; McCabe NP; Keck RW; Jankun J; Hampton JA; Selman SH
    Int J Oncol; 2005 Jan; 26(1):241-6. PubMed ID: 15586246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
    Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
    Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo.
    Bernardini G; Spinetti G; Ribatti D; Camarda G; Morbidelli L; Ziche M; Santoni A; Capogrossi MC; Napolitano M
    Blood; 2000 Dec; 96(13):4039-45. PubMed ID: 11110671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalein reduces angiogenesis in the inflammatory microenvironment via inhibiting the expression of AP-1.
    Huang Y; Miao Z; Hu Y; Yuan Y; Zhou Y; Wei L; Zhao K; Guo Q; Lu N
    Oncotarget; 2017 Jan; 8(1):883-899. PubMed ID: 27903990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
    Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
    Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.
    Ribatti D; Presta M; Vacca A; Ria R; Giuliani R; Dell'Era P; Nico B; Roncali L; Dammacco F
    Blood; 1999 Apr; 93(8):2627-36. PubMed ID: 10194442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells.
    Abe M; Inoue D; Matsunaga K; Ohizumi Y; Ueda H; Asano T; Murakami M; Sato Y
    J Cell Physiol; 2002 Jan; 190(1):109-16. PubMed ID: 11807817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
    Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
    J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo.
    Martínez-Poveda B; Muñoz-Chápuli R; Rodríguez-Nieto S; Quintela JM; Fernández A; Medina MA; Quesada AR
    Mol Cancer Ther; 2007 Oct; 6(10):2675-85. PubMed ID: 17938261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nitric oxide/cyclic GMP-mediated relaxation by purified flavonoids, baicalin and baicalein, in rat aortic rings.
    Huang Y; Wong CM; Lau CW; Yao X; Tsang SY; Su YL; Chen ZY
    Biochem Pharmacol; 2004 Feb; 67(4):787-94. PubMed ID: 14757179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells.
    Jeong A; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Bae H; Kim SH
    Biol Pharm Bull; 2010; 33(6):945-50. PubMed ID: 20522957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism.
    Brizzi MF; Battaglia E; Montrucchio G; Dentelli P; Del Sorbo L; Garbarino G; Pegoraro L; Camussi G
    Circ Res; 1999 Apr; 84(7):785-96. PubMed ID: 10205146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone.
    Ueda E; Ozerdem U; Chen YH; Yao M; Huang KT; Sun H; Martins-Green M; Bartolini P; Walker AM
    Endocr Relat Cancer; 2006 Mar; 13(1):95-111. PubMed ID: 16601282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.
    Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST
    Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.